Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by extracellular deposition of pathogenic amyloid-beta (Aβ) peptides, intracellular aggregation of hyperphosphorylated tau protein, and neuronal death.
Alzheimer's Disease Rodent Models
Although much progress has been made in AD research, the lack of an animal model that reproduces the complex spectrum of pathologies and cognitive symptoms of AD has hindered effective therapeutic development. Several of the neuropathological features of AD have been recapitulated by the introduction of APP, PS1, and PS2 transgenes into mice. [36] [37] [38] [39] [40] [41] The majority of transgenic animals exhibit cognitive deficits, amyloid peptide accumulation, and synaptic dysfunction without showing neurofibrillary tangle formation, overt neuronal death, or microglial activation. [42] [43] [44] [45] The creation of double-or triple-transgenic mice has increased the phenotypic similarities between animals and humans. 46, 47 However, several limitations of transgenic animal models of AD have been identified. First, the cerebrospinal fluid (CSF) of the brains of AD mice contains a constant high concentration of various Aβ peptide species, thereby complicating attempts to study the molecular bases of synaptic dysfunction; and second, the lack of neuronal death suggests that compensatory factors may be triggered by the introduction of transgenes into these mice. 48 As a complementary alternative to transgenic animal models, nontransgenic models of AD are valuable tools for studying the specific pathogenesis induced by Aβ. Similar to transgenic models, exogenous
Aβ administration does not reproduce the full complexity of human pathology. However, studies involving exogenous administration of Aβ have reported neurodegeneration and microglial activation, proximal to Aβ deposits. 49, 50 The exogenous Aβ administration model of AD has its own limitations as well. For example, injection/infusion of Aβ peptides is an invasive procedure, particularly when infusion is accomplished via osmotic pump. It introduces inevitable injury at the site of injection/ infusion, which possibly contributes to the induction of inflammatory processes. However, these limitations can be overcome to a significant degree by adjusting the infusion rate, the vehicle, the volume of injection, and the recovery time before examination of the animal to minimize the confounding effect of the procedure involved in administering Aβ.
During normal cellular metabolism, neurons secrete low levels of soluble Aβ peptides into the CSF and plasma. 51, 52 It has been suggested that the extent to which and the rate at which the pool of soluble Aβ oligomers forms insoluble amyloid fibrils are dependent on the rates of Aβ catabolism and clearance, which determine the amount of Aβ deposition and aggregation into amyloid plaques. [52] [53] [54] [55] We recently developed a novel AD at-risk model by intracerebroventricular (ICV) infusion of a nonpathogenic concentration of Aβ 1-42 for 14 days. Our at-risk rat model of AD is the first non-transgenic rat model that imitates a condition in which there is a heightened susceptibility to AD without any observable cognitive deficits.
Chronic Stress Accelerates and Intensifies Cognitive Deficits
A reliable and sensitive behavioral test for analyzing hippocampusdependent learning and memory is the radial arm water maze (RAWM).
It is a hybrid of the radial arm maze and the Morris water maze that combines the variable spatial complexity of the radial arm maze with the rapid motivated learning of the Morris water maze while minimizing their disadvantages.
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Four experimental groups were used in the study: control, stress, Aβ-treated, and stress/Aβ. The stress and stress/Aβ groups were subjected to stress for six weeks. In addition, the Aβ and Aβ/stress groups were infused with a mixture of Aβ On days six to eight of testing in the RAWM, the stress/Aβ rat group's ability to learn was significantly impaired compared with all other groups, including the Aβ group. For example, in trial four, stress/Aβ rats made significantly more errors in locating the hidden platform than the other rat groups, including Aβ rats. Furthermore, the Aβ group made significantly more errors than the control and stress rats. 16, 17 Both stress and Aβ groups revealed impairment of short-term memory compared with the control group. However, the stress/Aβ group showed significantly more impairment of short-term memory than all other groups.
These results were further confirmed by DTC values. In the learning phase, the stress/Aβ rats required approximately twice the number of days as did the control and stress groups to reach the criterion for learning.
Additionally, the Aβ group required significantly more days to reach the criterion than control and stress groups. 16 By contrast, DTC values were not significantly different between control and stress animal groups, 16 indicating that stress alone did not impair learning, which confirmed our published findings. 12 Thus, stress severely exacerbated learning deficits in cognitively impaired animals while having no effect on learning in normal animals. The short-term memory DTC values showed that chronic stress severely exacerbated Aβ-induced short-term memory deficits. This was indicated by nearly twice the number of days required by the stress/Aβ group compared with the stress and Aβ groups. 16 In our novel at-risk model, four groups were designated as control, stress, subAβ, and stress/subAβ. The results with the at-risk model showed that although the learning ability of rats of the sub-Aβ group (infused with 160pmol/day) was not different from that of the control group, that of the stress/sub-Aβ rats was markedly impaired compared with the other three experimental groups. 60 On days six to eight (see Figure 1) , the stress/sub-Aβ rats continued to commit significantly more errors in the short-term memory test than all other groups, including the stress group, which itself committed more errors than the control and subAβ groups. In addition, short-term memory was significantly more impaired in the stress/sub-Aβ groups than in the stress group (see Figure 1) . 60 These findings were further confirmed by the DTC of short-term memory. The stress/sub-Aβ rats required significantly (p<0.05) more days to reach the criterion than the other
Chronic Stress Accelerates and Intensifies Aβ-induced Alzheimer's-disease-like Pathogenesis in Rats three experimental groups. 60 As expected, 11 the stress group also required significantly more days to reach the DTC than the control and sub-Aβ groups.
Chronic Stress Reveals and Exacerbates Impairment of Synaptic Plasticity
To link cognitive deficits with possible changes in the cellular correlates of memory, we evaluated synaptic plasticity in area CA1 of the hippocampus. We recorded population spikes (pSpike) from area CA1 of anesthetized rats and measured the slope of field excitatory synaptic potential (fEPSP: a measure of synaptic strength) and spike amplitude (a measure of the number of neurons firing action potentials). 61 In these electrophysiological experiments, we first assessed basal synaptic function by applying a range of stimulus intensities to generate inputoutput (I/O) curves in control, stress, Aβ, and stress/Aβ group animals.
The I/O curves of the Aβ and stress/Aβ groups showed a significant rightward shift compared with those of the control and stress groups, indicating impaired basal synaptic transmission in these animals. 16 Early-phase long-term potentiation (LTP) is believed to be a cellular correlate of short-term memory. 62 We induced LTP by high-frequency stimulation (HFS) in the four groups of rats. Stimulation in control rats induced a robust LTP that lasted at least one hour after HFS. However, in stress/Aβ animals, immediately after HFS, LTP magnitude started to decay such that at 60 minutes post-HFS it completely disappeared down to baseline level. In Aβ and stress/Aβ rats, the pSpike LTP magnitude was significantly lower than that observed in stress rats at all points tested. 16 In the at-risk model, HFS induced robust LTP in the control and sub-Aβ animals. However, in both the stress and stress/sub-Aβ groups, although the magnitude of LTP was significantly higher than baseline 71 We found that the basal levels of calcineurin were increased significantly in the stress, Aβ, and stress/Aβ groups compared with those of the control group. 16 After induction of LTP by HFS, the levels of calcineurin in area CA1 were significantly (p<0.05) increased in all groups compared with the stimulated control.
In the at-risk model, one hour after the induction of LTP by HFS in area CA1 of the hippocampus, the levels of p-CaMKII in area CA1 were markedly increased in the stimulated control and stimulated sub-Aβ groups, but not in the stimulated stress and stimulated sub-Aβ/stress groups. 60 The levels of total CaMKII were significantly increased to similar levels in all stimulated groups after the induction of LTP. The levels of calcineurin were also significantly increased in all stimulated groups after the induction of LTP in the CA1 area of the hippocampus. 60 We have shown previously that chronic stress decreases basal levels of phosphorylated (p)-CaMKII in the CA1 region of anesthetized rats, and subsequently reduces the magnitude of HFS-induced LTP. 16, 72 Furthermore, the presence of abnormal levels of Aβ peptides has been shown to disrupt phosphorylation of CaMKII and interfere with LTP induction in both in vivo and in vitro studies. 16, 73, 74 Based on findings from our two models, we propose that the mechanism by which chronic
Neurodegenerative Disease Alzheimer's Disease We speculate that the neurotoxic effect of Aβ in the brain might be countered through repair, as suggested by the reported increased levels of NCAM. However, in the presence of chronic stress the ability of NCAM to repair is severely limited by the stress-induced reduction in the concentration of these protein molecules.
Another possibility is that stress may alter the processing and 
